Artelis introduces iCELLis™ 1000
Discover iCELLis™ 1000 - the next generation disposable bioreactor - at Interphex 2010 in New York. Click on the link below to learn more and watch the new video of iCELLis™ 1000
for additional information
CAB 2010
Meet us at the 11th Symposium on Computer Applications in Biotechnology (CAB) in Leuven, Belgium, from July 7th to 9th 2010.
for additional information
Process intensification by Artelis
iCELLis™ , fixed bed disposable technology.
for additional information

 

Sub-contracting

Artelis' CDO provides process development sub-contracting, from the pre-culture stage through purification to final filtration of the product.

Nowadays there are many Contract Manufacturing Organizations (CMOs) which subcontract manufacturing of clinical batches (injectable) and provide large-scale manufacturing capacity under GMP conditions.

Artelis provides the 'step before', i.e. teams skilled in bioprocesses, GMP-like* manufacturing capacities as well as an experience of the production constraints within the biopharmaceutical industry.

*Artelis uses the term 'GMP-like' to refer to the fact that environmental conditions are respected without the need for the laborious drafting of "good manufacturing processes". Thus Artelis customers are guaranteed that the processes developed by the company will be compatible when GMP conditions are implemented in the future.

CDO - Standard services

Artelis supplies members of its team and its infrastructure within the incubator to small technology companies Solvay in Belgium to meet customer needs. More on Standard services

CDO - Technology services

Artelis is actively seeking co-development contracts to adapt and validate its High Cell Density (HCD) Bioreactor to suit any processes used by any biotech company. More on Technology services